Skip Navigation

Cardiovascular Research 2002 55(2):385-395; doi:10.1016/S0008-6363(02)00409-1
© 2002 by European Society of Cardiology
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Theilmeier, G.
Right arrow Articles by Holvoet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theilmeier, G.
Right arrow Articles by Holvoet, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty

Gregor Theilmeiera,c,1, Rozenn Quarckb,1, Peter Verhammeb, Marie-Luce Bochaton-Piallatd, Marleen Loxb, Hilde Bernarb, Stefan Janssensa, Mark Kockxe, Giulio Gabbianid, Désiré Collena and Paul Holvoetb,*

aCenter for Molecular and Vascular Biology, Campus Gasthuisberg, O&N, Herestraat 49, B-3000 Leuven, Belgium
bCentre for Experimental Surgery and Anaesthesiology, Katholieke Universiteit Leuven, Campus Gasthuisberg, O&N, Herestraat 49, B-3000 Leuven, Belgium
cKlinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, University of Münster, Münster, Germany
dDepartment of Pathology—CMU, Geneva, Switzerland
eAZ—Middelheim and Department of Pharmacology, University of Antwerp, Antwerp, Belgium

* Corresponding author. Tel.: +32-16-34-7149; fax: +32-16-34-7114 paul.holvoet{at}med.kuleuven.ac.be

Received 15 October 2001; accepted 22 March 2002


   Abstract
Top
 Abstract
1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
Objective: To assess the effect of hypercholesterolemia on neointima formation and vascular remodelling after porcine coronary angioplasty. Methods: Left anterior descending coronary angioplasty was carried out in five control and 16 age-matched hypercholesterolemic miniature pigs. Vascular remodelling was measured by intravascular ultrasound. Neointima size and composition were assessed by quantitative image analysis. Coronary smooth muscle cells (SMC) from control and diet pigs were collected 1 h after angioplasty for in vitro study of the effect of hypercholesterolemic serum on SMC migration and of macrophage-induced matrix degradation on SMC adhesion. Results: Twenty-eight days after angioplasty, lumen increase was 0.08±1.7 mm2 in diet and 2.7±2.7 mm2 (P = 0.016) in control pigs. Lumen increase correlated with vascular remodelling (IELpost/IELpre; R2=0.59; P<0.001) and with the circumferential gain relative to the neointima (R2=0.32; P<0.01) but not with neointimal area that was similar in control and diet pigs. Circumferential gain correlated with VSMC deposition at the site of the injury (R2=0.28; P<0.01) that correlated with organized collagen (R2=0.34; P<0.01). The VSMC and collagen content of neointima in diet pigs was lower whereas the macrophage content was higher. Hypercholesterolemic serum and oxidised LDL reduced migration of VSMC from diet pigs. Macrophage-induced degradation of VSMC extracellular matrix reduced VSMC adhesion (P = 0.015). Conclusion: Hypercholesterolemia impairs vascular remodelling of balloon-treated coronary arteries. It decreases VSMC and collagen accumulation at the site of injury. Our in vitro data suggest that this decrease can be due to macrophage-induced matrix degradation and reduced VSMC adhesion and to impaired VSMC migration. Oxidised LDL mimics the inhibitory effect of hypercholesterolemic serum.

KEYWORDS Angioplasty; Atherosclerosis; Lipoproteins; Macrophages; Smooth muscle


   1. Introduction
Top
 Abstract
 1. Introduction
2. Methods
 3. Results
 4. Discussion
 References
 
Restenosis after successful percutaneous transluminal coronary angioplasty (PTCA) is due about 30% to neointima formation and about 70% to constrictive remodelling [1,2]. Cellular and molecular mechanisms leading to vessel constriction remain largely unknown. Alterations in collagen metabolism, apoptotic turnover and phenotypic changes in SMC have been implied [3,4]. Inflammatory responses in the adventitia can contribute to vascular remodelling in small animal models [5].

Hypercholesterolemia has been demonstrated to facilitate vascular shrinkage after balloon injury in animal models, but lipid-lowering strategies have failed to prevent restenosis after coronary angioplasty [6,7]. In the present study a model of coronary atherosclerosis in minipigs [8] was used to study the effect of LDL hypercholesterolemia on coronary artery remodelling in response to balloon injury. We observed impaired vascular remodelling and decreased late luminal gain after angioplasty in hypercholesterolemic miniature pigs that related to decreased vascular smooth muscle cell (VSMC) and collagen accumulation at the site of mechanical injury. To better understand the impact of hypercholesterolemia on VSMC accumulation and of matrix degradation on VSMC adhesion, we have studied the effect of control and hypercholesterolemic serum on VSMC migration and proliferation and of macrophage-induced extracellular matrix (ECM) degradation on VSMC adhesion in vitro. Furthermore, we investigated whether oxidised LDL can mimic the inhibitory effects of hypercholesterolemia on VSMC migration.


   2. Methods
Top
 Abstract
 1. Introduction
 2. Methods
3. Results
 4. Discussion
 References
 
2.1 Animal procedures
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). The Ethical Committee of the Katholieke Universiteit Leuven has approved the study. Sixteen miniature pigs were placed on a 4% cholesterol diet for 6–24 weeks before PTCA. Age-matched pigs were used as controls [8]. Lipid profiles were determined in the university hospital routine lab. Levels of circulating oxidised LDL were determined as previously described [9].

2.2 Coronary artery instrumentation and assessment of vascular remodelling
Coronary instrumentations were carried out in deep propofol anaesthesia as described before [10] and intravascular ultrasound (IVUS)-loops (IVUS Visons Five-64F/X, Endosonics, Zaventem, Belgium) of the proximal LAD were recorded. Areas of external elastic lamina (EEL), internal elastic lamina (IEL) and lumen were measured. In order to oversize the coronary arteries, a balloon (balloon/vessel ratio of 1.29±0.1) was inflated at 6 atm for 30 s in the mid-LAD of diet pigs and three times for 30 s in control pigs to match injury. A pilot experiment revealed that one balloon inflation for 30 s induced IEL rupture in only one out of four control pigs but in all diet pigs. Three balloon inflations resulted in IEL rupture in five out of five control pigs. At day 28, IVUS loops were obtained and EEL, IEL and lumen areas were determined by IVUS. Lumen change ({Delta}lumen) was calculated from recorded IVUS images as: lumenpost–lumenpre. The IELpost/IELpre ratio was calculated as a measure for vascular remodelling.

2.3 Vascular injury assessment
Arterial injury at the sites of maximal injury was assessed as described by Schwartz: 0, IEL intact; 1, rupture of IEL only; 2, media damage; and 3, EEL rupture [11].

2.4 Neointimal hyperplasia
Targeted LAD segments were sectioned at 7-µm thickness and a section every 70 µm was stained with Verhoeff-Von Gieson. A segment of 700 µm, spanning the maximal lesion, was used to assess neointima composition. Total lipid deposition in the lesions was determined by oil-red-O. Immunostaining was carried out for macrophages, oxidised LDL, SMC ({alpha}-actin and smoothelin), and collagen type I [8,12]. Blinded analysis was performed with the Quantimet 600 image analyser (Leica, Brussels, Belgium). A colour threshold mask for immunostaining was defined to detect the red or brown colour by sampling and the same threshold was applied to all samples. The lesion area with positive colour was recorded. The amount of total versus organized collagen was determined similarly by picrosirius red staining, viewed in normal versus polarized light [13,14]. A modified TUNEL protocol for the detection of apoptotic cells in complex tissues was used [15]. IEL fracture length to neointima ratio was calculated as a measure for the circumferential gain of the injured artery relative to neointima [10]. Diet-induced atherosclerosis in the absence of mechanical injury was assessed in the LCx as reference artery.

2.5 VSMC culture
One hour after PTCA, VSMC of injured coronary arteries from control and diet pigs were isolated using the explant-outgrowth method [16] and maintained in culture in Dulbecco's modified essential medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin. All experiments were carried out with cells of less than six passages.

2.6 LDL oxidation
LDL was isolated and oxidised in vitro, as previously described [17].

2.7 Proliferation and migration of VSMC
VSMC were seeded in 12- or six-well plates in DMEM-10% FBS. Sub-confluent cells were starved for 96 h in DMEM–0.2% FBS. To measure VSMC proliferation, 0.2% FBS, 10% FBS, 10% control pig serum (CPS), 10% diet pig serum (DPS) and 10 µg/ml pig oxidised LDL plus 0.5 µCi/ml of [3H]thymidine were added simultaneously for 48 h. Cells were washed twice with PBS. Trichloracetic acid-insoluble material was solubilized in 0.2 N NaOH and radioactivity was quantified in a β-scintillation liquid counter.

Cell migration was evaluated using a scratch wound assay [18]. The cell monolayer was scratched with a rubber policeman to generate a wound with a width of approximately 10 mm. The remaining cells were washed twice with 0.2% FBS, and 0.2% FBS, 10% CPS, 10% DPS or 10 µg/ml pig oxidised LDL were added for 48 h. VSMC were fixed in methanol, nuclei were stained using the May-Grünwald-Giemsa method [19] and the migrating cells and distance were assessed in 10 high power fields (hpf) along the scraped line.

2.8 Extracellular matrix production and synthesis
To produce ECM, VSMC were seeded in six-well plates in DMEM–10% FBS. Sub-confluent cells were maintained in DMEM–0.2% FBS for 9 days. SMC were lysed in 125 mM NH3 for 10 min at room temperature and ECM was washed five times in H2O and kept at 4 °C until use. To measure ECM synthesis, subconfluent cells were maintained in DMEM–0.2% FBS for 9 days, in the presence of 5 µCi/ml of L-[2,3,4,5-3H]proline (Amersham) that was renewed every 3 days [20]. Ascorbate (50 µg/ml) was added daily. SMC were lysed in 125 mM NH3 for 10 min at room temperature, ECM were washed five times in H2O and lysed in PBS containing 10 mM EDTA. Radioactivity contained in lysates was quantified in a β-scintillation liquid counter.

2.9 VSMC adhesion
Cell adhesion was evaluated according to a previously described protocol [21] with modifications. Human monocytoid THP-1 cells were seeded on plastic or on SMC ECM at 106 cells/well and differentiated by 10–7 M PMA for 72 h at 37 °C. After NH3 lysis of THP-1 cells, 125 000 SMC/well were seeded for 6 h and May-Grünwald-Giemsa positive cells were counted in 10 hpf. Data were expressed as the number of adhering cells per mm2.

2.10 Extracellular matrix degradation by macrophages
Radiolabeled VSMC-ECM was obtained as described above. After NH3 lysis of VSMC, THP-1 cells were differentiated and ECM degradation was estimated as cumulatively released cpm in the supernatant over total incorporated [3H]proline.

2.11 Statistics
Groups were compared by Mann–Whitney U-test. Correlations were determined by Spearman test. Linear regression was performed using the Prism program (GraphPad). Probability values of <0.05 were considered statistically significant.


   3. Results
Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
4. Discussion
 References
 
3.1 Plasma lipid levels
Table 1 demonstrates that the cholesterol diet induced a significant increase in total cholesterol, LDL-cholesterol and HDL-cholesterol but not of triglycerides within 4 weeks. Thereafter lipoprotein and lipid levels remained unchanged. Levels of circulating oxidised LDL were significantly higher in diet pigs (P<0.001; Table 1).


View this table:
[in this window]
[in a new window]

  		Table 1 Total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride and oxidised LDL levels in plasma of control and diet pigs

 
3.2 Acute lumen gain and vascular injury
The acute lumen gain in control and diet pigs was similar. The increase in luminal diameter was 8.7±3.7 and 5.9±5.6%, respectively. The injury score was also similar: 2.15±0.42 and 2.00±0.72, respectively.

3.3 Vascular remodelling and lumen change
Lumen area of coronary arteries from control and diet pigs before angioplasty was very similar as shown in Fig. 1. Twenty-eight days after angioplasty, the increase in lumen area was higher in control than in diet pigs (2.6±1.2 vs 0.08±0.42 mm2; Fig. 1). The IELpost/IELpre ratio was used as a measure for remodelling. This ratio was 1.88±0.33 in control pigs and 1.48±0.32 (P = 0.021) in diet pigs, indicating reduced vascular remodelling in diet pigs.


Figure 1
View larger version (55K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 1 IVUS evaluation of vascular remodelling of balloon-treated coronary arteries. Before angioplasty (pre), lumen area of coronary arteries of control and diet pigs was very similar. The LAD proximal of the second diagonal branch was subjected to balloon injury. Balloon injury was inflicted after matching the balloon-size for a balloon/vessel ratio of 1.3. In all pigs patent LADs were observed after balloon injury. No differences in acute gain were observed. Twenty-eight days after angioplasty (post), IVUS revealed a smaller increase in lumen area of the LAD from diet pigs compared to control pigs. The IELpost/IELpre ratio was smaller for diet pigs indicating reduced vascular remodelling. L, lumen, N, neointima; M, media.

 
At the end of the experiment, seven of 16 diet pigs had atherosclerotic lesions in the non-injured LCx (reference artery) that were greater than the mean±2 S.D. of control pigs (0.45±0.14 vs. 0.12±0.04 mm2; P<0.001). Pigs with pre-existing lesions were analysed separately from the other nine diet pigs in which the intimal area in the LCx was not different (0.07±0.03 mm2) from that in control pigs. No significant difference was noted between the two diet groups and the control group with respect to neointimal area 28 days after injury (3.42±1.22 vs. 2.96±1.51 vs. 3.72±0.81 mm2, respectively). The IELpost/IELpre ratio was similar for diet pigs with and without diet-induced atherosclerosis in the reference artery: 1.40±0.42 and 1.45±0.32, respectively. The lumen change was also similar for pigs with and without diet-induced atherosclerosis: 0.48±1.66 and –0.45±1.63, respectively.

3.4 Relation between VSMC at site of injury, circumferential gain, vascular remodelling and lumen change
Fig. 2 shows that lumen change correlated with the IELpost/IELpre ratio, as a measure for remodelling, and with the IEL fracture length-to-neointima ratio, as a measure for circumferential gain of the injured artery relative to neointima. Lumen change did not correlate with neointimal area (data not shown). The circumferential gain correlated with VSMC accumulation at the site of injury that correlated with organized collagen (Fig. 2).


Figure 2
View larger version (23K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 2 Relation between VSMC at site of injury, circumferential gain, vascular remodelling and lumen change. Lumen change correlated with the IELpost/IELpre ratio and with the IEL fracture length-to-neointima ratio. The circumferential gain correlated with VSMC accumulation at the site of injury that correlated with organized collagen.

 
3.5 Hypercholesterolemia and neointimal hyperplasia
Fig. 3 shows photomicrographs demonstrating density of lipids, macrophages, smooth muscle cells and collagen in balloon-treated coronary arteries from control and diet pigs. Hypercholesterolemia increased macrophage and lipid deposition and decreased SMC and collagen deposition. Lipid staining co-localised with macrophage accumulation. In LAD of diet pigs, lipid accumulation was observed at the base of the lesion where the IEL was ruptured, but also in the periphery of the lesions co-localising with macrophage accumulation. Here, only a few {alpha}-actin positive cells were observed and collagen detection revealed large gaps in the collagen web at these sites.


Figure 3
View larger version (116K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 3 Photomicrographs comparing accumulation of lipids, macrophages, smooth muscle cells and collagen in balloon-treated coronary arteries from control and diet pigs. In areas of macrophage accumulation in coronary arteries of diet pigs, no {alpha}-actin and collagen accumulation were observed (arrow heads indicate areas that are shown at larger magnification). In the LAD from diet pigs, lipid accumulation was observed at the base of the restenotic lesion where the IEL was ruptured, but also in the periphery of the lesions co-localizing with macrophage accumulation (arrow heads). Here, only few {alpha}-actin positive cells were observed and collagen staining revealed large gaps in the collagen web at these sites (arrow heads).

 
Fig. 4 shows mean intima, macrophage, lipid, vascular smooth muscle cell, collagen and organized collagen area in injured coronary arteries from control and diet pigs. Although mean neointimal areas in injured coronary arteries of control and diet pigs were very similar, differences in neointimal composition were observed. Neointima from diet pigs contained more macrophages, lipids and oxidised LDL (0.162±0.025 vs. 0.027±0.005 mm2, P = 0.001) and less SMC and (organized) collagen than control arteries (Fig. 4).


Figure 4
View larger version (27K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 4 Mean intima, macrophage, lipid, vascular smooth muscle cell, collagen and organized collagen content in injured coronary arteries from control and diet pigs. Although mean intima area in injured coronary arteries from control and diet pigs was very similar, differences in neointima composition were observed. Neointima from diet pigs contained more macrophages and lipids and less SMC and (organized) collagen than control arteries.

 
Collagen type I occupied 0.31±0.06 mm2 of neointima in control and 0.12±0.02 mm2 in diet pigs, respectively (P<0.01). The proportion of {alpha}-actin positive SMC that stained positively for smoothelin was not different among groups: 11.3±2.1% for control and 10.9±2.7% for diet pigs, indicating similarly differentiated VSMC.

Mean medial areas of targeted LAD segments were very similar in control and diet pigs: 1.44±0.29 and 1.20±0.56 mm2. The mean neointima/media ratio of injured segments of coronary arteries from control and diet pigs was very similar.

3.6 Relation between hypercholesterolemia and composition of neointima
Results are presented in Table 2. Lumen change was inversely related to hypercholesterolemia (R = –0.54; P = 0.005) that positively correlated with macrophages (R = 0.63; P = 0.002), lipids (R = 0.62, P = 0.002) and oxidised LDL (R = 0.59, P = 0.004), and negatively with VSMC (R = –0.59; P = 0.005) and organized collagen (R = –0.38, P = 0.018) accumulation in the neointima.


View this table:
[in this window]
[in a new window]

  		Table 2 Logistic regression analysis of the relation between hypercholesterolemia and neointima composition

 
3.7 Effect of hypercholesterolemia on VSMC proliferation and migration
First, the effect of in vivo exposure of VSMC to hypercholesterolemia on in vitro migration was tested. In the presence of 0.2% FBS (baseline conditions), migration of VSMC from injured arteries was similar to that of VSMC from intact arteries (Fig. 5A). Migration of VSMC from diet pigs was however significantly lower (P<0.01) compared to that of VSMC from control pigs in baseline conditions (Fig. 5A). Since injury had no significant effect on migratory features of VSMC, we further focused on the effect of hypercholesterolemia after angioplasty by comparing VSMC from control and diet pigs after injury. In the presence of 10% FBS, migration of VSMC from control pigs was similar to that of VSMC from diet pigs. It was threefold increased compared to baseline conditions (P<0.05) (Fig. 5B). Control pig serum induced a significant increase in migration of VSMC from control and diet pigs (P<0.001, P = 0.036, respectively) compared to 0.2% FBS (Fig. 5C). In the presence of diet pig serum, migration of VSMC from control pigs was similar to that in the presence of 0.2% FBS, whereas that of VSMC from diet pigs was significantly reduced. Oxidised LDL had no effect on migration of VSMC from control pigs compared to baseline conditions. In contrast, it significantly decreased migration of VSMC from diet pigs (P<0.05; Fig. 5C).


Figure 5
View larger version (27K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 5 Effect of hypercholesterolemia on VSMC migration and proliferation in vitro. Migration was evaluated using a scratch wound assay and proliferation by measuring [3H]thymidine incorporation. Migration of VSMC isolated from coronary arteries from control and diet pigs before and after injury in the presence of 0.2% FBS, *P<0.05 versus control pig (A), after injury in the presence of 10% FBS, *P<0.05 versus 0.2% FBS (B), after injury in the presence of 10% control pig serum (CPS), 10% diet pig serum (DPS) and 10 µg/ml oxidised LDL, *P<0.05 versus 0.2% FBS; #P<0.05 versus 10% CPS (C). Proliferation of VSMC isolated from coronary arteries from control and diet pigs after injury in the presence of 0.2% FBS, 10% FBS, 10% CPS, 10% DPS and 10 µg/ml pig oxidised LDL (D).

 
Proliferation of VSMC derived from diet pigs was higher than that of VSMC derived from control pigs. Proliferation of VSMC from control and diet pigs in the presence of 10% FBS, 10% control and 10% diet pig serum was similar (Fig. 5D).

3.8 Effect of macrophages on extracellular matrix degradation and VSMC adhesion
THP-1 cell-induced VSMC ECM degradation increased from 10–20% after 24 h to 60–70% after 5 days (Fig. 6A). Adhesion of VSMC to pre-digested ECM decreased by 55% compared to adhesion to native ECM (Fig. 6B). VSMC adhering to native ECM were well spread and flat (Fig. 6D) with a rich and well-organized net of {alpha}-actin fibres (Fig. 6F). In contrast, VSMC adhering to pre-digested ECM were skinny (Fig. 6E) with a less elaborated {alpha}-actin fibre structure (Fig. 6G).


Figure 6
View larger version (47K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 6 Effect of macrophages on VSMC-mediated repair in vitro. (A) VSMC ECM degradation by differentiated THP-1 cells. (B) Adhesion of VSMC from injured coronary arteries from diet pigs to plastic and to native ECM was counted in the presence and absence of differentiated THP-1 cells. (C) Synthesis of ECM by VSMC on native and pre-digested ECM by THP-1 cells in the presence of 0.2% FBS, CPS and DPS. *P<0.05 versus native ECM. Adhesion of VSMC to native ECM (D, F) and to pre-digested ECM by THP-1 (E, G) stained by May-Grünwald-Giemsa (D, E) and by a monoclonal antibody to SM {alpha}-actin (F, G).

 
When SMC were seeded on native ECM, control and diet pig serum had no effect on ECM synthesis by VSMC. When seeded on pre-digested ECM, VSMC synthesized more ECM in the presence of FBS and control serum. In contrast, diet pig serum failed to induce ECM synthesis (Fig. 6C).


   4. Discussion
Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
References
 
In agreement with findings in man, vascular remodelling rather than neointimal hyperplasia correlated with late lumen gain after porcine coronary angioplasty. Lumen change correlated with the circumferential gain of the injured artery that correlated with organized collagen deposition that depended on VSMC accumulation at the site of injury. In aggregate, our data indicate that accumulation of VSMC and deposition of VSMC matrix play a major role in vascular remodelling. This was hampered in the injured coronary arteries from hypercholesterolemic pigs that contained less VSMC and collagen but more macrophages.

Our in vitro studies showed that hypercholesterolemia in vivo as well as in vitro reduced migration of VSMC. Moreover, we demonstrated that oxidised LDL mimicked the effect of hypercholesterolemia. In contrast, proliferation was not affected by hypercholesterolemia in vitro. VSMC from diet pig displayed a higher proliferation rate in baseline conditions. Serum from hypercholesterolemic pigs induced an increase in VSMC proliferation similar to that obtained in the presence of 10% FBS, in accordance with previous studies [22]. Altogether our in vitro data suggest that the inhibitory effect of hypercholesterolemia on VSMC accumulation at the site of injury may be due to impaired VSMC migration rather than VSMC proliferation. Impaired VSMC-dependent repair function is most likely due to exposure of VSMC to plasma lipoproteins after vessel wall disruption, particularly to oxidised LDL as evidenced by the decrease in VSMC migration in the presence of oxidised LDL. Hypercholesterolemia was indeed associated with an increase in circulating oxidised LDL and led to higher oxidised LDL deposition in injured arteries of hypercholesterolemic pigs.

We observed less accumulation of SMC and collagen in macrophage-rich regions in the neointima in coronary arteries of diet pigs. This is in agreement with earlier observations that macrophages secrete metalloproteinases that degrade collagen [23]. We therefore studied the effect of macrophage-induced extracellular matrix degradation on VSMC adhesion in vitro. Adhesion of VSMC to matrix digested by differentiated THP-1 cells decreased by 55%. Our data are in agreement with earlier findings that in vitro macrophage-induced degradation of matrix components like collagen can decrease adhesion of VSMC [24]. In vivo, we observed that neointima size was similar in diet and control pigs after angioplasty, whereas the lesion composition was different, i.e. less accumulation of SMC and collagen and more accumulation of macrophages. In aggregate, the combination of our in vivo and in vitro data suggests that hypercholesterolemia has: (i) a direct effect via oxidised LDL on VSMC accumulation and (ii) an indirect effect via macrophages that by degrading ECM prevent SMC adhesion and thereby accumulation.

Previously we have isolated circulating oxidised LDL from the plasma of patients with cardiovascular disease and shown that its composition is very similar to that of oxidised LDL that has been isolated from atherosclerotic plaques [25]. Thus the effect of oxidised LDL present in the plasma may mimic that of oxidised LDL present in the plaque [26]. We have however to take into account that the oxidised LDL that is obtained by metal–ion induced oxidation is more extensively modified.

Positive vascular remodelling depends on ECM synthesis by VSMC to compensate the degradation of ECM by macrophages that accumulate after angioplasty [27]. We observed that macrophages co-localised with gaps in collagen where VSMC accumulated less in hypercholesterolemic pigs. In vitro, we observed that VSMC produced more matrix in the presence of control pig serum when seeded on digested matrix than when seeded on native ECM. In contrast, in the presence of hypercholesterolemic pig serum, VSMC failed to compensate ECM degradation by macrophages, in accordance with previous in vitro findings [28] and with our in vivo observations. The increased matrix production in response to macrophage-mediated matrix degradation was however impaired in the presence of hypercholesterolemic serum. An increase in matrix production could restore the ability of VSMC to migrate towards and adhere to an injured vessel wall segment in order to contribute to the repair process. Restoration of matrix did however not occur in the presence of hypercholesterolemic serum. Our in vitro data thus suggest an inhibitory effect of hypercholesterolemia on the healing capacity of VSMC by reducing their potential to produce extracellular matrix and are in agreement with the reduced VSMC accumulation in the macrophage-rich and collagen-poor areas in the neointima of diet pigs.

Production of matrix and dispersion of VSMC in the vessel wall has thus far been considered as disadvantageous and a key feature of neointima formation. Indeed will neointima, that does not stretch out circumferentially to serve as a neomedia, encroach the lumen and lead to restenosis? Our data, however, suggest that while hypercholesterolemia affects the amount of neointimal tissue only marginally, it impairs the ability of the vessel wall to utilize newly formed tissue for its expansion. This leads to an undesirable neointimal shaping in response to mechanical injury and consequent luminal encroachment due to the lack of vascular circumferential growth.

In humans, unfavourable remodelling accounts for up to 70% of clinical restenosis after coronary angioplasty. Probucol, a cholesterol-lowering agent with antioxidant properties, decreased restenosis by improving vascular remodelling [29,30]. Cholesterol lowering therapy improves coronary remodelling in patients with CAD [31]. Cholesterol-lowering agents such as statins failed to reduce the restenosis rate 4–6 months after angioplasty [30,32,33], although several trials seemed to show a beneficial effect [30,34,35]. It is however possible that cholesterol lowering has to be started many months before angioplasty to cause a reduction in macrophage and oxidised LDL content of the arteries and have an effect on restenosis rate.

In conclusion, we showed that hypercholesterolemia impairs vascular remodelling of balloon-treated coronary arteries. It increases macrophage accumulation and decreases VSMC accumulation at the site of injury. Our in vitro data indicate that hypercholesterolemia can impair VSMC migration and that macrophage-induced matrix degradation can reduce SMC adhesion resulting in impaired vascular remodelling after balloon dilatation in diet pigs.

Time for primary review 21 days.


   Acknowledgements
 
GT was the recipient of a research fellowship from the DFG, Bonn, Germany and is currently a member of the Interdisciplinary Centre for Clinical Research at the University of Münster. RQ was the recipient of a visiting postdoctoral fellowship from the Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen. PV is recipient of a research fellowship of the FWO-Vlaanderen. Interuniversitaire Attractiepolen (P5/01/02) to PH and FWO-Vlaanderen to PH (G.0088.02) and MK (G.0080.98N) supported this work.


   Notes
 
1 These authors contributed equally to the studies. Back


   References
Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 

  1. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation (1996) 94:1247–1254.[Abstract/Free Full Text]
  2. Post M.J., de Smet B.J., van der H.Y., et al. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation (1997) 96:996–1003.[Abstract/Free Full Text]
  3. Bauriedel G., Schluckebier S., Hutter R., et al. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol (1998) 18:1132–1139.[Abstract/Free Full Text]
  4. Shi Y., Pieniek M., Fard A., et al. Adventitial remodeling after coronary arterial injury. Circulation (1996) 93:340–348.[Abstract/Free Full Text]
  5. Labinaz M., Pels K., Hoffert C., et al. Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res (1999) 41:255–266.[Abstract/Free Full Text]
  6. Post M.J., Borst C., Kuntz R.E. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation (1994) 89:2816–2821.[Abstract/Free Full Text]
  7. Weintraub W.S., Boccuzzi S.J., Klein J.L., et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. N Engl J Med (1994) 331:1331–1337.[Abstract/Free Full Text]
  8. Holvoet P., Theilmeier G., Shivalkar B., et al. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol (1998) 18:415–422.[Abstract/Free Full Text]
  9. Holvoet P., Vanhaecke J., Janssens S., et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation (1998) 98:1487–1494.[Abstract/Free Full Text]
  10. Varenne O., Pislaru S., Gillijns H., et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation (1998) 98:919–926.[Abstract/Free Full Text]
  11. Schwartz R.S., Huber K.C., Murphy J.G., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol (1992) 19:267–274.[Abstract]
  12. Christen T., Verin V., Bochaton-Piallat M., et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation (2001) 103:882–888.[Abstract/Free Full Text]
  13. Junqueira L.C., Bignolas G., Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J (1979) 11:447–455.[CrossRef][ISI][Medline]
  14. Kockx M.M., De Meyer G.R., Buyssens N., et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res (1998) 83:378–387.[Abstract/Free Full Text]
  15. Sugimura T., Yokoi H., Sato N., et al. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation (1997) 96:3928–3933.[Abstract/Free Full Text]
  16. Rizvi M.A., Katwa L., Spadone D.P., et al. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol (1996) 28:243–252.[CrossRef][ISI][Medline]
  17. Holvoet P., Perez G., Bernar H., et al. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. J Clin Invest (1994) 93:89–98.[ISI][Medline]
  18. Herren B., Garton K.J., Coats S., et al. ADAM15 overexpression in NIH3T3 cells enhances cell–cell interactions. Exp Cell Res (2001) 271:152–160.[CrossRef][ISI][Medline]
  19. Ruben Z., Fuller G.C., Knodle S.G. Disobutamide-induced cytoplasmic vacuoles in cultured dog coronary artery muscle cells. Arch Toxicol (1984) 55:206–212.[CrossRef][ISI][Medline]
  20. Sansilvestri-Morel P., Nonotte I., Fournet-Bourguignon M.P., et al. Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins. J Vasc Res (1998) 35:115–123.[CrossRef][ISI][Medline]
  21. Poon M., Marx S.O., Gallo R., et al. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest (1996) 98:2277–2283.[ISI][Medline]
  22. Koschinsky T., Bunting C.E., Rutter R., et al. Increased growth stimulation of human vascular cells by serum from patients with primary hyper-LDL-cholesterolemia. Atherosclerosis (1987) 63:7–13.[CrossRef][ISI][Medline]
  23. de Smet B.J., de Kleijn D., Hanemaaijer R., et al. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig. Circulation (2000) 101:2962–2967.[Abstract/Free Full Text]
  24. Bacakova L., Herget J., Wilhelm J. Influence of macrophages and macrophage-modified collagen I on the adhesion and proliferation of vascular smooth muscle cells in culture. Physiol Res (1999) 48:341–351.[ISI][Medline]
  25. Holvoet P., Theilmeier G., Shivalkar B., et al. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol (1998) 18:415–422.[Abstract/Free Full Text]
  26. Hoff H.F., O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb (1991) 11:1209–1222.[Abstract/Free Full Text]
  27. Tyagi S.C. Vasculogenesis and angiogenesis: extracellular matrix remodeling in coronary collateral arteries and the ischemic heart. J Cell Biochem (1997) 65:388–394.[CrossRef][ISI][Medline]
  28. St Clair R.W., Jones D.C., Hester S.H. Failure of hypercholesterolemic serum to stimulate collagen synthesis in aortic smooth muscle cells from two species of nonhuman primates having different rates of collagen synthesis. Proc Soc Exp Biol Med (1983) 174:137–142.[Abstract]
  29. Tardif J.C., Cote G., Lesperance J., et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med (1997) 337:365–372.[Abstract/Free Full Text]
  30. Yokoi H., Daida H., Kuwabara Y., et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol (1997) 30:855–862.[Abstract]
  31. Hamasaki S., Higano S.T., Suwaidi J.A., et al. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol (2000) 20:737–743.[Abstract/Free Full Text]
  32. Bertrand M.E., McFadden E.P., Fruchart J.C., et al. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty. J Am Coll Cardiol (1997) 30:863–869.[Abstract]
  33. Kleemann A., Eckert S., von Eckardstein A., et al. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 20:1393–1406.[Abstract/Free Full Text]
  34. Hagenaars T, Gussenhoven EJ, van Sambeek MR et al. Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction. Am J Cardiol 2000;86:774–776, A6.
  35. Mulder H.J., Bal E.T., Jukema J.W., et al. Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial). Am J Cardiol (2000) 86:742–746.[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Theilmeier, G.
Right arrow Articles by Holvoet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theilmeier, G.
Right arrow Articles by Holvoet, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?